Literature DB >> 28282500

Morning symptoms in COPD: a treatable yet often overlooked factor.

Amanda R van Buul1, Marise J Kasteleyn1, Niels H Chavannes2, Christian Taube1.   

Abstract

INTRODUCTION: Chronic obstructive pulmonary disease (COPD) patients experience the morning as the worst period of the day. Nevertheless, morning symptoms are not mentioned in COPD guidelines. Areas covered: Different topics on morning symptoms are covered in this review to underline their importance: occurrence, tools for assessment and therapies to limit morning symptoms. Expert commentary: Morning symptoms are common and have a negative influence on a patient's life. Pharmacotherapy seems to be effective in decreasing morning symptoms. A validated tool to assess morning symptoms is lacking. Therefore, more research should focus on assessing morning symptoms with a validated tool to further prove the effect of (pharmaco-) therapy. This will hopefully result in inclusion of morning symptoms in future guidelines.

Entities:  

Keywords:  COPD; impact; morning symptoms; pharmacotherapy; questionnaires; review; symptoms; tools

Mesh:

Year:  2017        PMID: 28282500     DOI: 10.1080/17476348.2017.1305894

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  6 in total

1.  Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Cough and Sputum in Patients with COPD.

Authors:  Patrícia Rebelo; Ana Oliveira; Cátia Paixão; Carla Valente; Lília Andrade; Alda Marques
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-01-29

2.  The association between objectively measured physical activity and morning symptoms in COPD.

Authors:  Amanda R van Buul; Marise J Kasteleyn; Niels H Chavannes; Christian Taube
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-10-03

Review 3.  Recommendations for the pharmacological treatment of COPD: questions and answers.

Authors:  Frederico Leon Arrabal Fernandes; Alberto Cukier; Aquiles Assunção Camelier; Carlos Cezar Fritscher; Cláudia Henrique da Costa; Eanes Delgado Barros Pereira; Irma Godoy; José Eduardo Delfini Cançado; José Gustavo Romaldini; Jose Miguel Chatkin; José Roberto Jardim; Marcelo Fouad Rabahi; Maria Cecília Nieves Maiorano de Nucci; Maria da Penha Uchoa Sales; Maria Vera Cruz de Oliveira Castellano; Miguel Abidon Aidé; Paulo José Zimermann Teixeira; Renato Maciel; Ricardo de Amorim Corrêa; Roberto Stirbulov; Rodrigo Abensur Athanazio; Rodrigo Russo; Suzana Tanni Minamoto; Fernando Luiz Cavalcanti Lundgren
Journal:  J Bras Pneumol       Date:  2017 Jul-Aug       Impact factor: 2.624

4.  Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of GEM1 and GEM2 12-week studies.

Authors:  Jill A Ohar; Alyssa Bowling; Thomas Goodin; Barry Price; Ayca Ozol-Godfrey; Sanjay Sharma; Shahin Sanjar
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-02-19

5.  Daytime symptoms of chronic obstructive pulmonary disease: a systematic review.

Authors:  Ioanna Tsiligianni; Janwillem W H Kocks
Journal:  NPJ Prim Care Respir Med       Date:  2020-02-21       Impact factor: 2.871

6.  A Cross-Sectional Study in Patients with Severe COPD to Assess the Perception of Symptom Variability (COPVAR) in the Middle East and Africa.

Authors:  Nurdan Kokturk; Wael Abuharbid; Amr S Albanna; Hakan Gunen; Alev Gurgun; Mousa Khadadah; Elmas Malvolti; Medhat Soliman; Richard van Zyl-Smit; Noureddine Zidouni; Ashraf Alzaabi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-12-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.